You are currently viewing a new version of our website. To view the old version click .

Immune Correlates of Protection in Vaccines, 2nd Edition

This special issue belongs to the section “Vaccines, Clinical Advancement, and Associated Immunology“.

Special Issue Information

Dear Colleagues,

Characterizing immune correlates of protection is necessary to inform our understanding of pathogenesis and guide vaccine development. Previous vaccine efforts have underscored the crucial roles of both humoral and cellular immunity against viral pathogens and cancers. However, antibodies represent the primary correlate of immunity for most licensed vaccines. This Special Issue aims to expand our knowledge of immune responses, elicited naturally or by vaccination, and their contribution to protective efficacy. We cordially invite research articles and reviews that define the correlates of protection to distinguish between surrogates versus mechanisms of immunity. This Special Issue will cover the challenges that have emerged in determining the immune correlates of protection in vaccines, including innate immunity, B and T cell trained immunity, and so forth. We hope that these highlights will inform superior next-generation vaccine design.

Dr. Jingyou Yu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • vaccine
  • humoral immunity
  • cellular immunity
  • innate immunity
  • infectious disease
  • virus
  • cancer

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Vaccines - ISSN 2076-393X